| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
| AZD-8055 |
➤ Sign Up |
Compounds |
AstraZeneca AB (Sodertalje, SE) |
➤ Sign Up |
| AZD-8055 |
➤ Sign Up |
Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors |
Kudos Pharmaceuticals, Ltd. (London, GB) |
➤ Sign Up |
| AZD-8055 |
➤ Sign Up |
Process for the preparation of novel pyridopyrazines as mTOR kinase inhibitors |
AstraZeneca AB (Sodertalje, SE) |
➤ Sign Up |
| AZD-8055 |
➤ Sign Up |
Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors |
|
➤ Sign Up |
| AZD-8055 |
➤ Sign Up |
Anticancer compounds |
Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) |
➤ Sign Up |
| AZD-8055 |
➤ Sign Up |
Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors |
KUDOS PHARMACEUTICALS LIMITED (London, GB) |
➤ Sign Up |
| AZD-8055 |
➤ Sign Up |
Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof |
Intellikine LLC (La Jolla, CA) |
➤ Sign Up |
| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
